{
    "eid": "2-s2.0-85150311244",
    "title": "Implementation challenges and real-world impacts of switching pediatric vaccines: A global systematic literature review",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "adolescent",
        "child",
        "immunization program",
        "Pediatric",
        "switch",
        "systematic review",
        "vaccine"
    ],
    "authors": [
        "Chanthawat Patikorn",
        "Warittakorn Kategeaw",
        "Johnna Perdrizet",
        "Xiuyan Li",
        "Nathorn Chaiyakunapruk"
    ],
    "citedby-count": 0,
    "ref-count": 65,
    "ref-list": [
        "Introduction of inactivated poliovirus vaccine and switch from trivalent to bivalent oral poliovirus vaccine\u2014worldwide, 2013\u20132016",
        "Systematization of the introduction of IPV and switch from tOPV to bOPV in the Americas",
        "Implementing the synchronized global switch from trivalent to bivalent oral polio vaccines\u2014lessons learned from the global perspective",
        "Impact of switch options on the economics of pneumococcal conjugate vaccine (PCV) introduction in Indonesia",
        "Clinical and economic impact of a potential switch from 13-valent to 10-valent pneumococcal conjugate infant vaccination in Canada",
        "Follow-up of serotype distribution and antimicrobial susceptibility of streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in Belgium",
        "Should countries switch to using five- or ten-dose rotavirus vaccines now that they are available?",
        "Vaccine safety implications of Ontario, Canada\u2019s switch from DTaP-IPV to Tdap-IPV for the pre-school booster",
        "Impact of wastage on single and multi-dose vaccine vials: implications for introducing pneumococcal vaccines in developing countries",
        "Introducing multiple vaccines in low-and lower-middle-income countries: issues, opportunities and challenges",
        "Rotavirus vaccine introduction in the Americas: progress and lessons learned",
        "Inactivated poliovirus vaccine supply shortage: is there light at the end of the tunnel?",
        "Pneumococcal vaccination: what everyone should know [internet]",
        "Impact of 7-valent versus 10-valent pneumococcal conjugate vaccines on primary care consultations across various age groups in the Netherlands, 5 years after the switch: a time-series analysis",
        "Choosing between 7-, 10-and 13-valent pneumococcal conjugate vaccines in childhood: a review of economic evaluations (2006\u20132014)",
        "Pneumococcal vaccination in children: a systematic review and meta-analysis of cost-effectiveness studies",
        "Current situation, causes, and countermeasures to NIP vaccine shortages in Guangzhou, China",
        "Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022)",
        "Implementation challenges and impact of pediatric vaccine switches on immunization programs: a systematic literature review",
        "The PRISMA 2020 statement: an updated guideline for reporting systematic reviews",
        "Sanra\u2014a scale for the quality assessment of narrative review articles",
        "The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies",
        "Risk of bias in non-randomized studies - of exposure (ROBINS-E)",
        "A consensus-based checklist for reporting of survey studies (CROSS)",
        "The switch from trivalent to bivalent oral poliovirus vaccine in the South-East Asia Region",
        "Experiencia Argentina en la etapa final de erradicaci\u00f3n de la polio: cambio de vacuna oral trivalente a bivalente",
        "Introduction of inactivated polio vaccine, withdrawal of type 2 oral polio vaccine, and routine immunization strengthening in the Eastern Mediterranean region",
        "National introduction of fractional-dose inactivated polio vaccine in Sri Lanka following the global \u201cswitch\u201d",
        "Successes and challenges of expansion of environmental poliovirus surveillance in the WHO South-East Asia Region",
        "The polio endgame: rationale behind the change in immunisation",
        "Polio endgame: the global switch from tOPV to bOPV",
        "Experience with inactivated polio vaccine introduction and the \u201cSwitch\u201d from trivalent to bivalent oral polio vaccine in the World Health Organization\u2019s Western Pacific Region",
        "Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine \u2014 worldwide, 2016",
        "Considerations for the full global withdrawal of oral polio vaccine after eradication of polio",
        "Public health impact of pneumococcal conjugate vaccination: a review of measurement challenges",
        "Anti-polio vaccinations in the third millennia",
        "Goodbye switch and imminent polio victory",
        "Eradicating poliomyelitis: India\u2019s journey from hyperendemic to polio-free status",
        "Communications, immunization, and polio vaccines: lessons from a global perspective on generating political will, informing decision-making and planning, and engaging local support",
        "Sabin vaccine in poliomyelitis eradication: achievements and risks",
        "Eradicating polio: how the world\u2019s pediatricians can help stop this crippling illness forever",
        "The path towards polio eradication over 40 years of the expanded program on immunization in the Americas",
        "Fractional-dose inactivated poliovirus vaccine campaign \u2014 Sindh Province, Pakistan, 2016",
        "Whither pertussis?",
        "Introduction of inactivated poliovirus vaccine and trivalent oral polio vaccine/bivalent oral polio vaccine switch in the African Region",
        "Global polio eradication,The journey so far",
        "Decision making process, programmatic and logistic impact of the transition from a single-dose vial to a multi-dose vial of the 13-valent pneumococcal vaccine in Benin",
        "Impact of multiple injections on immunization rates among vulnerable children",
        "Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis, Burkina Faso, 2016\u20132017",
        "Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: time series analyses",
        "Switch from oral to inactivated poliovirus vaccine in Yogyakarta Province, Indonesia: summary of coverage, immunity, and environmental surveillance",
        "Use of a new combined vaccine in pediatric practices",
        "Costs of vaccine delivery in the Gambia before and after, pentavalent and pneumococcal conjugate vaccine introductions",
        "Stability of oral polio vaccine at different temperatures",
        "Assessing the potency and immunogenicity of inactivated poliovirus vaccine after exposure to freezing temperatures",
        "The influence of provider communication behaviors on parental vaccine acceptance and visit experience",
        "Misinformation of COVID-19 vaccines and vaccine hesitancy"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": null,
            "@id": "60014232",
            "affilname": "VA Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014232",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Salt Lake City",
            "@id": "60012445",
            "affilname": "University of Utah Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012445",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "New York",
            "@id": "60006989",
            "affilname": "Pfizer Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006989",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Taylor Ann Shufelt",
        "Pfizer Inc."
    ]
}